Metaplastic carcinoma of the breast: real-world outcome from a tertiary cancer centre in India.

Balasubramanian, Ananthi; Iyer, Priya; Ranganathan, Rama; Murhekar, Kanchan; Dhanushkodi, Manikandan; Ganesarajah, Selvaluxmy; Velusami, Sridevi; Krishnamurthy, Arvind

Balasubramanian, Ananthi; Iyer, Priya; Ranganathan, Rama; Murhekar, Kanchan; Dhanushkodi, Manikandan; Ganesarajah, Selvaluxmy; Velusami, Sridevi; Krishnamurthy, Arvind.

Afiliación

Balasubramanian A; Department of Radiation Oncology, Cancer Institute (WIA), Chennai 600 036, India.
Iyer P; 0000-0001-7107-8145.
Ranganathan R; Department of Radiation Oncology, Cancer Institute (WIA), Chennai 600 036, India.
Murhekar K; Department of Epidemiology and Cancer Registry, Cancer Institute (WIA), Chennai 600 036, India.
Dhanushkodi M; Department of Oncopathology, Cancer Institute (WIA), Chennai 600 036, India.
Ganesarajah S; Department of Medical Oncology, Cancer Institute (WIA), Chennai 600 036, India.
Velusami S; Department of Radiation Oncology, Cancer Institute (WIA), Chennai 600 036, India.
Krishnamurthy A; Department of Surgical Oncology, Cancer Institute (WIA), Chennai 600 036, India.

Ecancermedicalscience ; 16: 1429, 2022.

Article en En | MEDLINE | ID: mdl-36158987

Palabras clave

chemoresistance; metaplastic carcinoma; node-positive; receptor negative; triple negative

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ecancermedicalscience Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google